骨显像诊断转甲状腺素蛋白心脏淀粉样变的诊断准确性:系统评价与荟萃分析
该系统评价与荟萃分析纳入23项研究、3954例患者,评估骨显像对转甲状腺素蛋白心脏淀粉样变的诊断准确性。视觉平面分级与SPECT定量分析的诊断准确性(0.99)高于心脏与对侧比值(0.96);SPECT定量分析特异性最高(97%),其次为平面视觉分级(96%)和心脏与对侧比值(93%)。研究间异质性部分由疾病患病率差异解释。
要点
- 骨显像诊断转甲状腺素蛋白心脏淀粉样变准确性高,视觉平面分级与SPECT定量分析诊断准确性均为0.99。
- SPECT定量分析特异性97%,平面视觉分级96%,心脏与对侧比值93%。
- 研究间异质性部分由转甲状腺素蛋白心脏淀粉样变患病率差异解释。
核心结论
- 骨显像诊断转甲状腺素蛋白心脏淀粉样变准确性高,研究间异质性部分由疾病患病率差异解释。
- 各判读方法间特异性存在小幅差异,在低风险筛查人群中可能具有重要临床意义。
研究设计与样本
- 系统评价与荟萃分析,检索PUBMED和EMBASE自1990年至2023年2月关于骨显像诊断转甲状腺素蛋白心脏淀粉样变准确性的研究。
- 最终纳入23项研究,共3954例患者,其中1337例(39.6%)诊断为转甲状腺素蛋白心脏淀粉样变,患病率范围21%至73%。
- 采用分层模型确定汇总受试者工作特征曲线及操作点。
主要发现
- 视觉平面分级与定量分析的诊断准确性均为0.99,高于心脏与对侧比值的0.96。
- SPECT定量分析特异性最高(97%),其次为平面视觉分级(96%)和心脏与对侧比值(93%)。
- 转甲状腺素蛋白心脏淀粉样变患病率解释了部分研究间异质性。
关键数值与推荐
- 视觉平面分级诊断准确性0.99。
- 定量分析诊断准确性0.99。
- 心脏与对侧比值诊断准确性0.96。
- SPECT定量分析特异性97%。
- 平面视觉分级特异性96%。
局限性
- 研究间存在异质性,部分由转甲状腺素蛋白心脏淀粉样变患病率差异解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bone scintigraphy imaging is frequently used to investigate patients with suspected transthyretin cardiac amyloidosis (ATTR-CM). However, the reported accuracy for interpretation approaches has changed over time. We performed a systematic review and meta-analysis to determine the diagnostic accuracy of visual planar grading, heart-to-contralateral (HCL) ratio, and quantitative analysis of SPECT imaging and evaluate reasons for shifts in reported accuracy. METHODS: We performed a systematic review to identify studies of the diagnostic accuracy of bone scintigraphy for ATTR-CM from 1990 until February 2023 using PUBMED and EMBASE. Studies were reviewed separately by two authors for inclusion and for risk of bias assessment. Summary receiver operating characteristic curves and operating points were determined with hierarchical modeling. RESULTS: Out of a total of 428 identified studies, 119 were reviewed in detail and 23 were included in the final analysis. The studies included a total of 3954 patients, with ATTR-CM diagnosed in 1337 (39.6%) patients and prevalence ranging from 21 to 73%. Visual planar grading and quantitative analysis had higher diagnostic accuracy (.99) than HCL ratio (.96). Quantitative analysis of SPECT imaging had the highest specificity (97%) followed by planar visual grade (96%) and HCL ratio (93%). ATTR-CM prevalence accounted for some of the observed between study heterogeneity. CONCLUSIONS: Bone scintigraphy imaging is highly accurate for identifying patients with ATTR-CM, with between study heterogeneity in part explained by differences in disease prevalence. We identified small differences in specificity, which may have important clinical implications when applied to low-risk screening populations.
引用
- Ahluwalia N, Roshankar G, Draycott L, et al. Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis. J Nucl Cardiol. 2023. PMID: 37226006. doi:10.1007/s12350-023-03297-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。